# Prevalence of Myocardial Scars on CMR After COVID-19 Infection

Study · id `cardio:ct-nct04636320` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04636320](<https://clinicaltrials.gov/study/NCT04636320>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04636320

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.

## Technical summary

Registry record NCT04636320. Non-randomized; no masking; primary purpose diagnostic. Start 2020-06-13 (actual); primary completion 2022-04-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 231 participants (enrolled count; ClinicalTrials.gov record NCT04636320, source copy `cardio:ctgov-nct04636320-2023-03-16`, retrieved 2026-10-26)
- Started: 2020-06-13 (actual) (ClinicalTrials.gov record NCT04636320, source copy `cardio:ctgov-nct04636320-2023-03-16`, retrieved 2026-10-26)
- Primary completion: 2022-04-04 (actual) (ClinicalTrials.gov record NCT04636320, source copy `cardio:ctgov-nct04636320-2023-03-16`, retrieved 2026-10-26)
- Completion: 2022-04-04 (actual) (ClinicalTrials.gov record NCT04636320, source copy `cardio:ctgov-nct04636320-2023-03-16`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT04636320, source copy `cardio:ctgov-nct04636320-2023-03-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04636320-2023-03-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevalence of Myocardial Scars on CMR After COVID-19 Infection
- Acronym: COVID-CMR
- Condition: COVID-19
- Condition: Virus Disease
- Intervention (Device): Contrast-enhanced CMR
- Intervention (Diagnostic test): Exercise test ECG
- Intervention (Biological): Blood sample
- Intervention (Diagnostic test): Resting 12 lead ECG
- Intervention (Diagnostic test): 24 hour Holter ECG
- Lead sponsor: University Hospital, Bordeaux
- Lead sponsor class: OTHER
- Collaborator: Grant Agreement ERC n°715093
- Collaborator class: UNKNOWN
- Collaborator: University of Bordeaux
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: University Hospital, Bordeaux (`cardio:org-university-hospital-bordeaux`)

## Provenance

Content hash: c2d276d8a5d99436b5c7b1d8d2233ac7724d6d62f248781e05771f5db46394d3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
